Search Results - "Acs, Annabel"

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 by Einarson, Thomas R, Acs, Annabel, Ludwig, Craig, Panton, Ulrik H

“…Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes (T2DM). CVD's prevalence has been growing over time. To estimate the current prevalence…”
Get full text

Effect of Organization-Directed Workplace Interventions on Physician Burnout: A Systematic Review by DeChant, Paul F., Acs, Annabel, Rhee, Kyu B., Boulanger, Talia S., Snowdon, Jane L., Tutty, Michael A., Sinsky, Christine A., Thomas Craig, Kelly J.

“…To assess the impact of organization-directed workplace interventions on physician burnout, including stress or job satisfaction in all settings, we conducted…”
Get full text

Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review by Einarson, Thomas R., Acs, Annabel, Ludwig, Craig, Panton, Ulrik H.

“…Cardiovascular diseases (CVDs) constitute major comorbidities in type 2 diabetes mellitus (T2DM), contributing substantially to treatment costs for T2DM. An…”
Get full text

Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes by Einarson, Thomas R., Bereza, Basil G., Acs, Annabel, Jensen, Rasmus

“…Background: Undetected/uncontrolled diabetes is associated with substantial morbidity and mortality and consequent costs. Early detection through screening…”
Get full text

Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in Canada by Fenu, Elisabetta, Lukyanov, Vasily, Acs, Annabel, Radu, Xenia, Stypa, Stephanie, Fischer, Aren, Marshall, John K., Oppe, Mark

“…Background and Objectives Ulcerative colitis is highly prevalent in Canada and cost-effective ulcerative colitis therapies are warranted. Vedolizumab…”
Get full text

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye by White, Darrell E, Zhao, Yang, Ogundele, Abayomi, Fulcher, Nicole, Acs, Annabel, Moore-Schiltz, Laura, Karpecki, Paul M

“…To assess adherence, non-persistence, discontinuation, and switching of topical cyclosporine ophthalmic emulsion 0.05% (CYC) and lifitegrast ophthalmic…”
Get full text